In T2-T3 stage CRC, CD90+ CAFs are the main source of IL-6 in the tumor microenvironment and can promote the expression of stem cell markers ALDH and Lgr5 in cancer cells, thereby promoting cancer development (69). This evidence concerns the gene IL6 and cancer.